diazoxide , an inhibitor of insulin release in vivo and in vitro , inhibits the islet mitochondrial glycerol phosphate dehydrogenase in all three of the assays mentioned above at concentrations that inhibit insulin release and co2 formation from glucose by isolated pancreatic islets .
C0021641
insulin
C0022131
pancreatic islets